You are here: Home / About Us / Board of Visitors

Board of Visitors

Joseph T. Abdalla '89, MBA
inPractice & Clinical Care Options

George Abercrombie '78, MBA

Paul J. Atkins, PhD
Vice President of Operations
Oriel Therapeutics

Paul W. Bush, PharmD, MBA
Chief Pharmacy Officer
Duke University Hospital

James W. Crow
Founder, President, and Chief Operating Officer (Retired)
United Therapeutics, Inc.

Catherine Crumpton, MS '86
President
Alizarin, Inc.

Marty DeBerardinis, PhD ‘82
Director, Medicines Evaluation–Infection
AstraZeneca Pharmaceuticals LP

Fred Eshelman '72, PharmD
Chairman
Furiex Pharmaceuticals

Neal Fowler '84, MBA '88
CEO
Liquidia Technologies

Joe Graedon, MS
President
Graedon Enterprises, Inc.
The People’s Pharmacy

Mark Gregory
Vice President of Pharmacy and Government Relations
Kerr Drug, Inc.

Donna Gutterman, PharmD, MBA
President
Onesta Inc.

Reg Hardy ’81, MBA
President
BrickellBiotech

Jimmy Jackson
Spoke Consulting, Inc.

M. Ross Johnson, PhD
President and CEO
Parion Sciences, Inc.

Martin D. Marciniak, MPP, PhD
Vice President
US Health Outcomes and Medical Policy
GlaxoSmithKline

Douglas W. Mendenhall, PhD
dwm Consulting, LLC

David S. Moody '73
CEO
Mutual Drug Company

William “Whit” Moose '60
Past President, NCPA
Moose Drug Company

Louis A. Newsome '77
Pharmacy Program Executive, Mid-Atlantic Region
UnitedHealthcare of North Carolina

John Uhrin, RPh '76
Lure Management, LLC

P. Kay Wagoner, PhD
Immediate Past President and CEO
Icagen, Inc.

Chris L. Waller, PhD '92
Senior Director, HealthCare Informatics
Medical Business Technology
Pfizer



Document Actions